Top 15 drug patent losses for 2013 - FiercePharma: http://t.co/OY7qDd87...
Via Lionel Reichardt / le Pharmageek
Share ideas that matter on the social web and experience
the benefits of curating the world's best content.
I don't have a Facebook, a Twitter or a LinkedIn account
Your new post is loading...
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Andrew Spong's curator insight,
April 8, 7:05 AM
Everyone wants the fastest, most accurate diagnosis they can acquire (although they may also want a second decision). Clinical decision support tools can help deliver on this requirement in a timely manner.
To me, this article is suggesting that there is an educational need for doctors who use diagnostic tools to explain to their patients why they are using them, *not* a suggestion that they stop using them.
Deborah Verran's comment,
April 9, 4:40 PM
Important that everyone in the healthcare system understand what are the challenges with conveying why this technology is being used, to the public
Steve S Ryan, PhD's curator insight,
April 16, 9:34 PM
[SSR: Never underestimate the value of asking for expert advise. It makes you look smart to use multiple resoucres.] Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
hugh mcclung's curator insight,
May 14, 12:22 AM
Compliance is a big problem. A number of vendors have developed mobile apps around a game approach. Fun is a solid solution. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Sven Awege's curator insight,
May 3, 4:09 AM
Insightful article by Michelle from EPG Health Media. Looking at the overwhelming information here the task ahead is mammoth. Baby steps, baby steps.
Try small things, test, measure, refine.
As the article highlights, Pharma Markers are mostly influenced by past experience, so we need to get them actually doing stuff and demonstrating the value (yes, force them to focus on the important things to measure, and not just "interactions"). Only then will we be able to make the case for the real investmetns necessary to truely operate in a multi-channel/cross-channel manner (but that's another ball game all toegether). Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Sven Awege's curator insight,
May 3, 9:17 PM
This is a platform all Pharma marketers should know about. It's going to scare you, as it will revolutionize how you think about your marketing, but the rewards will be worth it. Potentially there is a need for agencies to work with this platform to offer carefully crafted solutions for the marketers who never have enough time! Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
|
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
hugh mcclung's curator insight,
May 9, 10:12 PM
Great simple summary of what is missing from hosptials marketing programs Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
rob halkes's curator insight,
May 3, 1:10 PM
It is not an easy task to change pharma's market approach: ever since 2002, it has been grown into a firmly standardized routine for all pharma companies. Product oriented detailing was the name of the game. But markets have changed in the meantime and have become different by structure, reimbursement and price. Avoiding the commodity trap is challenging. Here is a short review of how we changed in the Netherlands and put customer first. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
|